Citations (24)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (2)
Zia ur Rehman & Asim Najmi. (2023) Exploring EGFR inhibitors with the aid of virtual screening, docking, and dynamics simulation studies. Journal of Biomolecular Structure and Dynamics 0:0, pages 1-21.
Read now
Read now
Herbert B Newton. (2002) Chemotherapy for the treatment of metastatic brain tumors. Expert Review of Anticancer Therapy 2:5, pages 495-506.
Read now
Read now
Articles from other publishers (22)
Herbert B. Newton, Ramya Tadipatri & Ekokobe Fonkem. 2022. Handbook of Neuro-Oncology Neuroimaging. Handbook of Neuro-Oncology Neuroimaging
25
37
.
Herbert B. Newton, Seema Shroff & Mark G. Malkin. 2022. Neurological Complications of Systemic Cancer and Antineoplastic Therapy. Neurological Complications of Systemic Cancer and Antineoplastic Therapy
79
95
.
D. Samuel Metibemu, O. Adeboye Akinloye, A. Jamiu Akamo, D. Ajiboye Ojo, O. Tolulope Okeowo & I. Olaposi Omotuyi. (2019) Exploring receptor tyrosine kinases-inhibitors in Cancer treatments. Egyptian Journal of Medical Human Genetics 20:1.
Crossref
Crossref
Herbert B. Newton. 2018. Handbook of Brain Tumor Chemotherapy, Molecular Therapeutics, and Immunotherapy. Handbook of Brain Tumor Chemotherapy, Molecular Therapeutics, and Immunotherapy
527
543
.
Herbert B. Newton. 2016. Handbook of Neuro-Oncology Neuroimaging. Handbook of Neuro-Oncology Neuroimaging
23
33
.
Takahiro Amemiya, Masashi Honma, Yoshiaki Kariya, Samik Ghosh, Hiroaki Kitano, Yoshihisa Kurachi, Ken-ichi Fujita, Yasutsuna Sasaki, Yukio Homma, Darrel R Abernethy, Haruki Kume & Hiroshi Suzuki. (2015) Elucidation of the molecular mechanisms underlying adverse reactions associated with a kinase inhibitor using systems toxicology. npj Systems Biology and Applications 1:1.
Crossref
Crossref
Herbert B. Newton & Jose J. Otero. 2015. Epilepsy and Brain Tumors. Epilepsy and Brain Tumors
29
43
.
Fernando López, Cristina García Inclán, Jhudit Pérez-Escuredo, César Álvarez Marcos, Bartolomé Scola, Carlos Suárez, José Luis Llorente & Mario A. Hermsen. (2012) KRAS and BRAF mutations in sinonasal cancer. Oral Oncology 48:8, pages 692-697.
Crossref
Crossref
Ming Liu & Daniel Hicklin. 2011. Tumor Models in Cancer Research. Tumor Models in Cancer Research
99
124
.
Walter Kolch & Andrew Pitt. (2010) Functional proteomics to dissect tyrosine kinase signalling pathways in cancer. Nature Reviews Cancer 10:9, pages 618-629.
Crossref
Crossref
Herbert B. Newton, Abhik Ray-Chaudhury & Mark G. Malkin. 2008. Handbook of Neuro-Oncology NeuroImaging. Handbook of Neuro-Oncology NeuroImaging
20
30
.
A E Carie & S M Sebti. (2007) A chemical biology approach identifies a beta-2 adrenergic receptor agonist that causes human tumor regression by blocking the Raf-1/Mek-1/Erk1/2 pathway. Oncogene 26:26, pages 3777-3788.
Crossref
Crossref
Leon SmithIIII, Wai C. Wong, Alexander S. Kiselyov, Sabina Burdzovic-Wizemann, Yunyu Mao, Yongjiang Xu, Matthew A.J. Duncton, Ki Kim, Evgueni L. Piatnitski, Jacqueline F. Doody, Ying Wang, Robin L. Rosler, Daniel Milligan, John Columbus, Chris Balagtas, Sui Ping Lee, Andrey Konovalov & Yaron R. Hadari. (2006) Novel tricyclic azepine derivatives: Biological evaluation of pyrimido[4,5-b]-1,4-benzoxazepines, thiazepines, and diazepines as inhibitors of the epidermal growth factor receptor tyrosine kinase. Bioorganic & Medicinal Chemistry Letters 16:19, pages 5102-5106.
Crossref
Crossref
Sai-Ching Jim Yeung. 2006. Thyroid Neoplasms. Thyroid Neoplasms
117
144
.
Herbert B. Newton. 2006. Handbook of Brain Tumor Chemotherapy. Handbook of Brain Tumor Chemotherapy
475
489
.
Francesco Trapasso, Manuela Sarti, Rossano Cesari, Sai Yendamuri, Kristoffel R Dumon, Rami I Aqeilan, Francesca Pentimalli, Luisa Infante, Hansjuerg Alder, Nobutsugu Abe, Takashi Watanabe, Giuseppe Viglietto, Carlo M Croce & Alfredo Fusco. (2004) Therapy of human pancreatic carcinoma based on suppression of HMGA1 protein synthesis in preclinical models. Cancer Gene Therapy 11:9, pages 633-641.
Crossref
Crossref
Toru Nakamura, Yoichi Furukawa, Hidewaki Nakagawa, Tatsuhiko Tsunoda, Hiroaki Ohigashi, Kohei Murata, Osamu Ishikawa, Kazuhisa Ohgaki, Nobuichi Kashimura, Masaki Miyamoto, Satoshi Hirano, Satoshi Kondo, Hiroyuki Katoh, Yusuke Nakamura & Toyomasa Katagiri. (2004) Genome-wide cDNA microarray analysis of gene expression profiles in pancreatic cancers using populations of tumor cells and normal ductal epithelial cells selected for purity by laser microdissection. Oncogene 23:13, pages 2385-2400.
Crossref
Crossref
Hayley S. Ramshaw, Timothy R. Hercus, Ian N. Olver & Angel F. Lopez. 2004. Hematopoietic Growth Factors in Oncology. Hematopoietic Growth Factors in Oncology
447
465
.
Anette Weber, Larissa Langhanki, Florian Sommerer, Annett Markwarth, Christian Wittekind & Andrea Tannapfel. (2003) Mutations of the BRAF gene in squamous cell carcinoma of the head and neck. Oncogene 22:30, pages 4757-4759.
Crossref
Crossref
Zhi-Yong Wang, Qian Zhang, John Wilson, Mariusz Z. Ratajczak & Mariusz A. Wasik. (2003) Detection of Protein Tyrosine-Kinase (PTK) Gene Expression Pattern in Normal and Malignant T Lymphocytes by Combined PTK-Specific Polymerase Chain Reaction and Parallel Denaturing Gradient Gel Electrophoresis. The Journal of Molecular Diagnostics 5:2, pages 113-120.
Crossref
Crossref
K. K. Jain. (2016) Proteomics-based Anticancer Drug Discovery and Development. Technology in Cancer Research & Treatment 1:4, pages 231-236.
Crossref
Crossref
Elizabeth M Jaffee, Ralph H Hruban, Marcia Canto & Scott E Kern. (2002) Focus on pancreas cancer. Cancer Cell 2:1, pages 25-28.
Crossref
Crossref